Skip to main content
Signal8

Lakefront Biotherapeutics NV (LKFT)

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Lakefront Biotherapeutics N.V. logo

Lakefront Biotherapeutics N.V.

NASDAQ:LKFTHealthcare
+2.38%$34.79
CLOSED
AH$34.79+0.00%vs close
Mkt Cap$2.29B
EV-
Float65.9M
O/S65.9M
VOL293K sh
$ Vol$10.16M
RVOL1.13×
Inst Own48.1%
Net Cash/Sh-
Dilution
Lakefront Biotherapeutics N.V. logoNASDAQ:LKFTClosed$34.79+2.38%
Historical Data
DateOpenHighLowCloseVolume
Nov 16, 202634.5035.1534.4534.79292,602
Nov 13, 202633.7234.1433.2233.98287,838
Nov 12, 202634.2035.5433.7533.93535,522
Nov 11, 202632.9933.4232.9533.34195,183
Nov 10, 202632.9533.4832.8033.41228,631
Nov 9, 202633.8034.1533.3333.52325,971
Nov 6, 202632.3033.6032.2733.45374,143
Nov 5, 202634.0934.4933.5133.56342,321
Nov 4, 202633.0934.1332.8534.09447,220
Nov 3, 202632.2532.4531.9832.15129,706
Nov 2, 202632.4432.5031.9032.02259,070
Oct 30, 202632.4232.7632.0632.28164,056
Oct 29, 202632.2432.6032.0132.33245,964
Oct 28, 202631.6532.4131.5132.08268,990
Oct 27, 202631.5731.8231.2731.82170,822
Oct 26, 202631.8132.0031.6231.68191,351
Oct 23, 202631.3631.7931.1931.65294,937
Oct 22, 202630.6231.5330.5531.40307,947
Oct 21, 202630.7530.8630.3630.58134,158
Oct 20, 202629.9730.8629.9730.75293,687
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target (median, last 90d)
$45.00+29.3%
Low $45High $45
Ratings Distribution
BUY
1
HOLD
1
SELL
0
TOTAL2
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
48.1%
Institutional
(95)
0.0%
Insiderⓘ
(0)
0.0%
5%+ Owners
(0)
51.9%
Unattributed (incl. retail)ⓘ
Institutional48.1%
Unattributed (incl. retail)51.9%
Sources: 13F, 13D/13GO/S: 65.9M · checked 16 Nov 2026 · market-data provider
Insiders & Institutional Holders
About

Galapagos NV is a biotechnology company that specializes in the discovery and advancement of novel small molecule and antibody-based therapeutics.

Its active clinical development programs include drugs like filgotinib and GLP3667, alongside the Toledo program and therapies targeting idiopathic pulmonary fibrosis.

The firm was established on June 30, 1999, by co-founders Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es, and maintains its headquarters in Mechelen, Belgium.

Key Metrics
Market Cap$2.29B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership48.07%

based on 65.90M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
CountryBEBE
IPO DateMay 5, 2005
Shares Outstanding65.90M
Authorized Shares
Float65.90M
52-Week Range
$26.42$37.78
$34.79(74th percentile)
Volume
Average Daily Volume268.08K
292.62K today vs 268.08K avg(+9%)

30d Avg

268.08K

60d Avg

290.02K

90d Avg

284.13K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Lakefront Biotherapeutics NV (NASDAQ: LKFT) traded at $34.79 on Nov 16, 2026, up 2.38% from the previous close of $33.98. 52-week range: $26.42 to $37.78. The company is in the Healthcare sector (Biotechnology).